| Region: | |
| Category: |
(49 reports matching your criteria)
|
Cough, Cold and Allergy (Hay Fever) Remedies in Australia
3/7/2013 | published by: Euromonitor International
... roughly in line with the CAGR of the review period. The rising prevalence of hay fever was a significant contributing factor to the growth in cough, cold, and allergy (hay fever) remedies sales. Euromonitor International's ...
|
read more...
|
$900.00
|
|
Dermatologicals in Australia
3/7/2013 | published by: Euromonitor International
... population. Both children and the elderly have sensitive skin, and are susceptible to allergies and skin conditions, thus the category is benefiting from this Euromonitor International's Dermatologicals in Australia report offers a comprehensive guide to ...
|
read more...
|
$900.00
|
|
Digestive Remedies in Australia
3/7/2013 | published by: Euromonitor International
... played important roles in the sales performance of Australia’s digestive remedies. Euromonitor International's Digestive Remedies in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It ...
|
read more...
|
$900.00
|
|
Emergency Contraception in Australia
3/7/2013 | published by: Euromonitor International
... Australia since 2004, thus the category is still maturing. Euromonitor International's Emergency Contraception in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the ...
|
read more...
|
$900.00
|
|
NRT Smoking Cessation Aids in Australia
3/7/2013 | published by: Euromonitor International
... impact of plain packaging for tobacco products are the two greatest areas of interest for operators within NRT smoking cessation aids in Australia. Euromonitor International's NRT Smoking Cessation Aids in Australia report offers a comprehensive ...
|
read more...
|
$900.00
|
|
PharmaPoint: Prostate Cancer - Australia Drug Forecast and Market Analysis to 2022
12/31/2012 | published by: GlobalData
... of second-line metastatic castration-resistant prostate cancer (mCRPC) therapies like J&J’s Zytiga (abiraterone acetate) and Medivation/Astellas’ Xtandi (enzalutamide) will drive strong market growth over the next decade. These safe and orally administered treatments will provide safety ...
|
read more...
|
$4,995.00
|
|
Optometry and Optical Dispensing in Australia - Industry Market Research Report
12/11/2012 | published by: IBISWorld
... It also includes establishments with optical dispensers, mainly engaged in dispensing spectacles or contact lenses, and registered orthoptists mainly engaged in diagnosing and treating ocular muscle disorders. This report covers the scope, size, disposition and ...
|
read more...
|
$970.00
|
|
Psychiatric Hospitals in Australia - Industry Market Research Report
12/3/2012 | published by: IBISWorld
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
|
read more...
|
$970.00
|
|
New Zealand Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
11/30/2012 | published by: GlobalData
... Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others” provides key market data on the New Zealand Anesthesia and Respiratory Devices ...
|
read more...
|
$2,500.00
|
|
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update
11/30/2012 | published by: GlobalData
... is currently very dynamic, with the November 6, 2012 FDA approval of Pfizer’s Xeljanz (tofacitinib) and novel oral therapies awaiting approval such as: Eli Lilly’s anti-BAFF, tabalumab and JAK1,2 inhibitor, baricitinib, and Rigel/AZ’s SYK inhibitor, ...
|
read more...
|
$4,995.00
|
|
Australia Cardiovascular Monitoring Systems Market Trends Forecast To 2018
11/13/2012 | published by: ABMRG
... ECG Stress Testing Systems Holter Monitoring System Event Monitoring Systems Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. ...
|
read more...
|
$2,100.00
|
|
Australia Cardiovascular Surgery Market Trends Forecast To 2018
11/13/2012 | published by: ABMRG
... Cardiac Ablation Devices Cardiopulmonary Bypass Equipment Perfusion Disposables Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights and ...
|
read more...
|
$2,100.00
|
|
Australia Cardiovascular Devices Market Outlook Through 2018
11/13/2012 | published by: ABMRG
... product type, growth Trendss and market shares of companies at sector and category level. It’s vital “cross category comparison” and “cross sub-category comparison” section makes analysis very handy for company professionals. The report helps professionals ...
|
read more...
|
$3,000.00
|
|
Dental Services in Australia - Industry Market Research Report
11/7/2012 | published by: IBISWorld
... outpatient services only are also included in the industry. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, ...
|
read more...
|
$970.00
|
|
Incontinence in New Zealand
6/12/2012 | published by: Euromonitor International
... of incontinence aid increased. As a result of these factors, incontinence saw retail volume sales growth of 3% in 2011, while current value sales saw growth of 7%. Euromonitor International's Incontinence in New Zealand report ...
|
read more...
|
$900.00
|
|
Australia Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters
4/25/2012 | published by: GlobalData
... Equipment and Lithotripters” provides key market data on the Australia Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three ...
|
read more...
|
$2,500.00
|
|
New Zealand Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters
4/25/2012 | published by: GlobalData
... Renal Dialysis Equipment and Lithotripters” provides key market data on the New Zealand Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and ...
|
read more...
|
$2,500.00
|
|
Australia Cardiovascular Monitoring Systems Market - Present and Future Trends Until 2018
4/4/2012 | published by: ABMRG
... Testing Systems Holter Monitoring System Event Monitoring Systems Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights and ...
|
read more...
|
$2,000.00
|
|
Australia Cardiovascular Surgery Market - Present and Future Trends Until 2018
4/4/2012 | published by: ABMRG
... Devices Cardiopulmonary Bypass Equipment Perfusion Disposables Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights and compares key ...
|
read more...
|
$2,000.00
|
|
Digestive Remedies in New Zealand
3/8/2012 | published by: Euromonitor International
... continued within digestive remedies during 2011. Euromonitor International's Digestive Remedies in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail ...
|
read more...
|
$900.00
|
|
Emergency Contraception in New Zealand
3/8/2012 | published by: Euromonitor International
... 2010 to NZ$45.91 in 2011. During 2009, the Auckland District Health Board spent NZ$300,000 on a trial and paid pharmacies to make Levonelle available for free for five months ending in March 2009. The free ...
|
read more...
|
$900.00
|
|
NRT Smoking Cessation Aids in New Zealand
3/8/2012 | published by: Euromonitor International
... occurred during 2010, when the government implemented a range of excise tax increases levied on cigarettes, cigars, cigarillos and loose tobacco. As a result of these changes, there was a surge in the number of ...
|
read more...
|
$900.00
|
|
Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand
3/8/2012 | published by: Euromonitor International
... reclassify these two drugs considering the fact they are active ingredients used in the manufacture of the Class A controlled drug methamphetamine. Prior to the reclassification, pseudoephedrine was available over the counter in cold and ...
|
read more...
|
$900.00
|
|
Psychiatric Hospitals in Australia - Industry Risk Rating Report
1/20/2012 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$990.00
|
|
Dental Services in Australia - Industry Risk Rating Report
1/20/2012 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$990.00
|